Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors Affecting Motivation among Key Populations to Engage with Tuberculosis Screening and Testing Services in Northwest Tanzania: A Mixed-Methods Analysis.
Khaji RA, Kabwebwe VM, Mringo AG, Nkwabi TF, Bigio J, Mergenthaler C, Aguilera Vasquez N, Pande T, Rahman MT, Haraka F. Khaji RA, et al. Among authors: haraka f. Int J Environ Res Public Health. 2021 Sep 14;18(18):9654. doi: 10.3390/ijerph18189654. Int J Environ Res Public Health. 2021. PMID: 34574579 Free PMC article.
Pulmonary aspergilloma: a treatment challenge in sub-Saharan Africa.
Pohl C, Jugheli L, Haraka F, Mfinanga E, Said K, Reither K. Pohl C, et al. Among authors: haraka f. PLoS Negl Trop Dis. 2013 Oct 24;7(10):e2352. doi: 10.1371/journal.pntd.0002352. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24205413 Free PMC article. No abstract available.
Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.
Zifodya JS, Kreniske JS, Schiller I, Kohli M, Dendukuri N, Schumacher SG, Ochodo EA, Haraka F, Zwerling AA, Pai M, Steingart KR, Horne DJ. Zifodya JS, et al. Among authors: haraka f. Cochrane Database Syst Rev. 2021 Feb 22;2:CD009593. doi: 10.1002/14651858.CD009593.pub5. Cochrane Database Syst Rev. 2021. PMID: 33616229
Effect of history of tuberculosis on specificity of Xpert MTB/RIF.
Haraka F, Schumacher SG, Ross A, Mantsoki A, Gagneux S, Reither K, Denkinger CM. Haraka F, et al. Eur Respir J. 2020 Sep 24;56(3):2000343. doi: 10.1183/13993003.00343-2020. Print 2020 Sep. Eur Respir J. 2020. PMID: 32409573 Free article. No abstract available.
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.
Tweed CD, Dawson R, Burger DA, Conradie A, Crook AM, Mendel CM, Conradie F, Diacon AH, Ntinginya NE, Everitt DE, Haraka F, Li M, van Niekerk CH, Okwera A, Rassool MS, Reither K, Sebe MA, Staples S, Variava E, Spigelman M. Tweed CD, et al. Among authors: haraka f. Lancet Respir Med. 2019 Dec;7(12):1048-1058. doi: 10.1016/S2213-2600(19)30366-2. Epub 2019 Nov 12. Lancet Respir Med. 2019. PMID: 31732485 Free PMC article. Clinical Trial.
18 results